Cargando…
Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells
A major challenge to tuberculosis (TB) vaccine development is the lack of a validated immune correlate of protection. Mycobacterial growth inhibition assays (MGIAs) represent an unbiased measure of the ability to control mycobacterial growth in vitro. A successful MGIA could be applied to preclinica...
Autores principales: | Tanner, Rachel, Smith, Steven G., van Meijgaarden, Krista E., Giannoni, Federico, Wilkie, Morven, Gabriele, Lucia, Palma, Carla, Dockrell, Hazel M., Ottenhoff, Tom H.M., McShane, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926177/ https://www.ncbi.nlm.nih.gov/pubmed/30710562 http://dx.doi.org/10.1016/j.jim.2019.01.006 |
Ejemplares similares
-
The perspective on standardisation and harmonisation: the viewpoint of the EASI president
por: Damoiseaux, Jan
Publicado: (2020) -
Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines
por: Smith, Steven G., et al.
Publicado: (2015) -
Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection
por: Betts, Gareth, et al.
Publicado: (2012) -
TB vaccine development: where are we and why is it so difficult?
por: Wilkie, Morven E M, et al.
Publicado: (2015) -
Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
por: Dockrell, Hazel M., et al.
Publicado: (2022)